<DOC>
	<DOCNO>NCT00872716</DOCNO>
	<brief_summary>The study hypothesis quetiapine XR anxiolytic property . The study aim investigate putative anxiolytic property quetiapine XR patient anxiety disorder . Therefore , proof-of-concept design patient simple phobia select investigate specific anxiolytic antipanic activity acute anxiety . Moreover , combine fMRI/visual stimulus presentation paradigm activity fear-network associate brain structure amygdala investigate treatment quetiapine XR placebo . Additionally , genetic factor potentially mediate anxiolytic property quetiapine study .</brief_summary>
	<brief_title>Quetiapine Specific Phobia</brief_title>
	<detailed_description />
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision write informed consent A diagnosis simple phobia Diagnostic Statistical Manual Mental DisordersFourth Edition ( DSMIV ) Females male age 18 70 year Females childbearing potential must negative serum pregnancy test within 7 day prior enrolment willing use effective method birth control duration study . Effective method birth control define result low failure rate ( i.e . pearlindex &lt; 1 % ) use consistently correctly : hormonal oral , transdermal , injectable contraceptive agent doublebarrier method ; implantable contraceptive device failure rate le 1 % least 3 month prior enrolment ; vasectomize partner Able understand comply requirement study Pregnancy lactation Any DSMIV Axis I disorder define inclusion criterion Patients , opinion investigator , pose imminent risk suicide danger self others Known intolerance lack response quetiapine fumarate judge investigator Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir Use follow cytochrome P450 3A4 inducer 14 day precede enrolment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid Administration depot antipsychotic injection within one dose interval ( depot ) randomization Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment Medical condition would affect absorption , distribution , metabolism , excretion study treatment Unstable inadequately treat medical illness ( e.g . congestive heart failure , angina pectoris , hypertension ) judge investigator Involvement planning conduct study Previous enrolment randomization treatment present study . Participation another drug trial within 4 week prior enrolment study long accordance local requirement A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrolment glycosylated hemoglobin ( HbA1c ) &gt; 8.5 % ; Admitted hospital treatment DM DM relate illness past 12 week ; Not physician care DM ; Physician responsible patient 's DM care indicate patient 's DM control ; Physician responsible patient 's DM care approve patient 's participation study ; Has dose oral hypoglycaemic drug ( ) and/or diet 4 week prior randomization . For thiazolidinediones ( glitazones ) period le 8 Weeks ; Taking insulin , daily dose one occasion past 4 week 10 % mean dose precede 4 week . Note : If diabetic patient meet one criterion , patient exclude even treat physician believe patient stable participate study . An absolute neutrophil count ( ANC ) &lt; = 1.5 x 109 per liter Exclusion criterion magnetic resonance imaging procedure : cardiac pacemaker defibrillator ; injure metallic object NOT remove ; cochlear ( ear ) implant ; surgery involve metallic implant ( e.g . knee replacement ) ; weight 300 lbs/136 kg ( weight limit scanner bed ) ; IntraUterine Device ( IUD ) ; claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>specific phobia</keyword>
	<keyword>simple phobia</keyword>
	<keyword>anxiety disorder</keyword>
</DOC>